BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17392174)

  • 21. Expression of vascular endothelial growth factor and its receptors in canine lymphoma.
    Wolfesberger B; Guija de Arespacohaga A; Willmann M; Gerner W; Miller I; Schwendenwein I; Kleiter M; Egerbacher M; Thalhammer JG; Muellauer L; Skalicky M; Walter I
    J Comp Pathol; 2007 Jul; 137(1):30-40. PubMed ID: 17467003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.
    Favier J; Igaz P; Burnichon N; Amar L; Libé R; Badoual C; Tissier F; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
    Endocr Pathol; 2012 Mar; 23(1):34-42. PubMed ID: 22183643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma.
    Ho CL; Sheu LF; Li CY
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):316-21. PubMed ID: 12607599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma.
    Wagner SD; Amen F; Trivedi PS; Horncastle D; Elderfield K; Naresh KN
    Leuk Lymphoma; 2007 Aug; 48(8):1510-3. PubMed ID: 17701581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis.
    Soini Y; Salo T; Satta J
    Hum Pathol; 2003 Aug; 34(8):756-63. PubMed ID: 14506635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).
    Gratzinger D; Advani R; Zhao S; Talreja N; Tibshirani RJ; Shyam R; Horning S; Sehn LH; Farinha P; Briones J; Lossos IS; Gascoyne RD; Natkunam Y
    Br J Haematol; 2010 Jan; 148(2):235-44. PubMed ID: 19821819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.
    Suzuki S; Dobashi Y; Hatakeyama Y; Tajiri R; Fujimura T; Heldin CH; Ooi A
    BMC Cancer; 2010 Nov; 10():659. PubMed ID: 21118571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.
    Berglund M; Thunberg U; Amini RM; Book M; Roos G; Erlanson M; Linderoth J; Dictor M; Jerkeman M; Cavallin-Ståhl E; Sundström C; Rehn-Eriksson S; Backlin C; Hagberg H; Rosenquist R; Enblad G
    Mod Pathol; 2005 Aug; 18(8):1113-20. PubMed ID: 15920553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma.
    Ferreira CV; Siqueira DR; Romitti M; Ceolin L; Brasil BA; Meurer L; Capp C; Maia AL
    Int J Mol Sci; 2014 Mar; 15(4):5323-36. PubMed ID: 24675699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAFF-R is expressed on B-cell lymphomas depending on their origin, and is related to proliferation index of nodal diffuse large B-cell lymphomas.
    Takahata H; Ohara N; Ichimura K; Tanaka T; Sato Y; Morito T; Takata K; Kojima M; Kobata T; Yoshino T
    J Clin Exp Hematop; 2010; 50(2):121-7. PubMed ID: 21123970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.
    Vacca A; Ribatti D; Fanelli M; Costantino F; Nico B; Di Stefano R; Serio G; Dammacco F
    Leuk Lymphoma; 1996 Aug; 22(5-6):473-81. PubMed ID: 8882961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
    Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor expression in low and high grade B-cell non-Hodgkin's lymphomas.
    Ozbudak IH; Akkaya B; Karpuzoğlu G
    Turk Patoloji Derg; 2011; 27(3):204-9. PubMed ID: 21935869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of VEGF-A and Microvessel Density in Diffuse Large B-Cell Lymphoma and Low-Grade Follicular Lymphoma.
    Shahini L; Gašparov S; Petruševska G; Manxhuka Kerliu S; Veselaj F; Kurshumliu F; Kavaja F
    Acta Clin Croat; 2017 Dec; 56(4):588-593. PubMed ID: 29590710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases.
    Hattab EM; Martin SE; Al-Khatib SM; Kupsky WJ; Vance GH; Stohler RA; Czader M; Al-Abbadi MA
    Mod Pathol; 2010 Feb; 23(2):235-43. PubMed ID: 19935644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival.
    Haarer CF; Roberts RA; Frutiger YM; Grogan TM; Rimsza LM
    Arch Pathol Lab Med; 2006 Dec; 130(12):1819-24. PubMed ID: 17149956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas.
    Bairey O; Zimra Y; Kaganovsky E; Shaklai M; Okon E; Rabizadeh E
    Med Oncol; 2000 Nov; 17(4):314-8. PubMed ID: 11114711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.
    Capp C; Wajner SM; Siqueira DR; Brasil BA; Meurer L; Maia AL
    Thyroid; 2010 Aug; 20(8):863-71. PubMed ID: 20615131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
    Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
    Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.